论文信息 - Efficacy of combination treatment using YHO-1701, an orally active STAT3 inhibitor, with molecular-targeted agents on cancer cell lines - 字舞流文

Efficacy of combination treatment using YHO-1701, an orally active STAT3 inhibitor, with molecular-targeted agents on cancer cell lines

A. Asai | F. Nishisaka | K. Taniguchi | M. Tsugane | Hiroyuki Takahashi | Y. Shishido | H. Konishi | A. Yoshinaga